Pyk2 promotes tumor progression in multiple myeloma - Wikidata - awgldk - TriplyDB

Pyk2 promotes tumor progression in multiple myeloma

Pyk2 promotes tumor progression in multiple myeloma

http://www.wikidata.org/entity/Q34398382

about

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc Mitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver.Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.A Dual Role for the Nonreceptor Tyrosine Kinase Pyk2 during the Intracellular Trafficking of Human Papillomavirus 16.Rap2B GTPase: structure, functions, and regulation.Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.Multiple myeloma in the marrow: pathogenesis and treatments.Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy Structural Basis for the Interaction between Pyk2-FAT Domain and Leupaxin LD Repeats.CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation.The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.Kinase inhibitors as potential agents in the treatment of multiple myeloma.The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling.Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma.Targeting the programmed death-1 pathway in lymphoid neoplasms.The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer.Pyk2 promotes tumor progression in renal cell carcinoma

P2860

Q26795594-87A81BF0-6FE1-419F-AE22-8D1854EAC393 Q28559676-34F6B17C-D7A9-434F-A61C-777781DC9BF4 Q34627493-37245085-7F89-4A1A-9B12-261B47E8BF43 Q35778422-FC52658B-9BFC-4509-9E9F-244015B16924 Q35913900-55584543-7BB7-41E7-A2F3-F69414B94291 Q35969641-4600DB99-B2DC-4AEE-9A8A-78B3C970ECCA Q36711842-A51A1BC4-5F86-4860-AC27-B4E124F1D862 Q36725401-EE9FC21A-D10D-4E17-AC43-E0873E0897A1 Q36737884-664E3B3E-1233-4BB2-809D-606E0C2A7555 Q36832332-F2AD3BDD-90F8-48DE-AB9A-B69EDEB5F803 Q37127055-55D37A05-B4DF-4B03-9CA5-F78AEC837D0F Q37665665-8659E1F5-66A6-42C2-8E3C-BE08E6E8B322 Q37697253-9E304AB6-5120-473D-82F5-49678A7D4C1C Q38656507-41D1689C-811F-43CB-856F-48F8C91F565D Q38853857-E3778E0D-C388-4582-88D8-03EE5842942A Q39153358-C532EBF2-8812-4EE1-AD5B-ECEE91D02437 Q40969084-DD28DE1D-7E6E-4D69-9229-E22E92AC9BF3 Q54111596-DD1F95DB-195B-4A68-81D1-35A5ACBFBF33 Q57788719-3D8CA15E-3E4F-40D7-8EE3-2C727F42E5C2

P2860

Pyk2 promotes tumor progression in multiple myeloma

http://www.wikidata.org/entity/Q34398382

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Pyk2 promotes tumor progression in multiple myeloma

@ast

Pyk2 promotes tumor progression in multiple myeloma

@en

Pyk2 promotes tumor progression in multiple myeloma

@nl

type

label

Pyk2 promotes tumor progression in multiple myeloma

@ast

Pyk2 promotes tumor progression in multiple myeloma

@en

Pyk2 promotes tumor progression in multiple myeloma

@nl

prefLabel

Pyk2 promotes tumor progression in multiple myeloma

@ast

Pyk2 promotes tumor progression in multiple myeloma

@en

Pyk2 promotes tumor progression in multiple myeloma

@nl

P1433

Q34398382-9639E26E-7AD6-475A-ABD2-E1F366C77180

P1476

Q34398382-4933D7CB-272D-4930-962A-93CAF89AA9CD

P2093

Q34398382-11801043-2C8F-4131-B8FA-60F54D1A2BC0

Q34398382-16B13EBC-4449-4110-AC3F-4ACD37C67C4E

Q34398382-2A1D3CE6-0594-49BA-B038-DB774916328D

Q34398382-7E688060-D494-4477-94A5-E95660F6CD34

Q34398382-8578D7D2-A2D3-4362-AAB3-8FED18277E47

Q34398382-8F7F31FF-212E-4BD6-ABC5-AAB7A2BBD7E0

Q34398382-90E94F79-727F-476A-A176-C6BB418A5207

Q34398382-97E6294B-C946-42CD-9927-65A7E13B0D4C

Q34398382-98C79817-258A-4288-8F2D-613E462B8C5D

Q34398382-AAD0DFB5-F455-46D5-B21D-791B80ABC1F9

P2860

Q34398382-01B722C9-596B-46EF-848F-6AEED5E666AE

Q34398382-074A97F4-4FFE-4B34-AEA2-9DA14B053960

Q34398382-0C1BEEEF-4D20-4A9A-BF4D-BEECE07B6FAC

Q34398382-16EAAD19-C1D9-4A78-AFA2-539B2B52139C

Q34398382-189DFDF9-A43D-40D3-BFD0-FDB17BDB6A07

Q34398382-1CBD8108-82C0-4A5F-9824-B108BEB8AAB7

Q34398382-1D435A48-6D95-44D4-8956-36FE14A2F6ED

Q34398382-1E80F69A-9FD7-4D54-953C-0422841D7D20

Q34398382-2510879A-6232-41F5-BF57-5CF761BB6602

Q34398382-27F49B42-166B-405A-9B83-950EAE6B9B6E

P304

Q34398382-107078B4-0A52-482B-AB24-2E0004F971EA

P31

Q34398382-231BE410-8D53-4006-99AA-E43075B59616

P356

Q34398382-9CAB1229-4ACA-4730-95BB-FD6FFF4B644F

P407

Q34398382-3C982356-0075-452B-9A02-4FB00F650FBB

P433

Q34398382-13F875DE-8CF2-4EF3-BD5E-9B140AE77DA6

P478

Q34398382-74B3D1B0-A029-413B-B168-71C3EB2DCE79

P50

Q34398382-22319278-661C-49C2-B82D-21CB9C8CBD94

Q34398382-380E81E0-A09F-4783-8C81-16A778E6B82F

Q34398382-610FC3D8-DE6D-4A79-860F-C31BF22B5B95

Q34398382-B2A24B3E-EC94-457F-B93A-5D4E5D7342E0

Q34398382-F88F5361-2F7E-44AE-86D6-2AE71A789109

P577

Q34398382-BCE0B936-5BC2-419B-99B4-B6D3B93944F3

P5875

Q34398382-38D20798-A59F-4984-9E1C-164B49BB7B88

P698

Q34398382-911698C8-B866-4634-992D-C98DDE849CAA

P932

Q34398382-F627A945-31C1-4EB3-9006-43A5516F07E1

P356

BLOOD-2014-03-563981

P1433

P1476

Pyk2 promotes tumor progression in multiple myeloma

@en

P2093

Daisy Huynh

http://www.w3.org/2001/XMLSchema#string

Ilyas Sahin

http://www.w3.org/2001/XMLSchema#string

Irene M Ghobrial

http://www.w3.org/2001/XMLSchema#string

Jennifer E Ring

http://www.w3.org/2001/XMLSchema#string

Jonathan Pachter

http://www.w3.org/2001/XMLSchema#string

Michele Moschetta

http://www.w3.org/2001/XMLSchema#string

Nikhil C Munshi

http://www.w3.org/2001/XMLSchema#string

Qunli Xu

http://www.w3.org/2001/XMLSchema#string

Salomon Manier

http://www.w3.org/2001/XMLSchema#string

Siobhan Glavey

http://www.w3.org/2001/XMLSchema#string

P2860

SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells

Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions

A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation

Activation of Pyk2 by stress signals and coupling with JNK signaling pathway

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia

The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after beta1-integrin stimulation in B cells and binds to p130cas

Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration.

Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis.

P304

2675-2686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-03-563981

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Michaela R. Reagan

Kenneth C Anderson

P577

2014-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265607092

http://www.w3.org/2001/XMLSchema#string

P698

25217697

http://www.w3.org/2001/XMLSchema#string

P932

4208283

http://www.w3.org/2001/XMLSchema#string